2023 annual financial data
Aquestive Therapeutics 2023 Operating margin
Direct answer
Operating margin was -29.86%.
Operating income was -15,102,000 USD and net income was -7,870,000 USD.
Operating cash flow was -6,380,000 USD.
Get free Aquestive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 50,583,000 USD
- Operating income
- -15,102,000 USD
- Net income
- -7,870,000 USD
- Operating cash flow
- -6,380,000 USD